• Skip to content
  • Jump to main navigation and login

Nav view search

Navigation

Search

  • Versión Español
  • English version

ISSUE BIOSALUD

  • Presentation
  • Basic Information
  • Editorial Commitee
  • International Commitee
  • Technical Commitee
  • Last issue
  • Collection
  • Ethics Policy
  • Formats
  • Guidelines for authors
  • Vinaora Visitors Counter
mod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_counter
mod_vvisit_counterToday4
mod_vvisit_counterYesterday29
mod_vvisit_counterThis week33
mod_vvisit_counterLast week361
mod_vvisit_counterThis month33
mod_vvisit_counterLast month2381
mod_vvisit_counterAll days183643

Online Now: 2
Your IP: 3.238.7.202
,
Today: March 02, 2021
Visitors Counter

 

Mario Herrera-Marschitz MD, PhD Department of Physiology

and Pharmacology. Karolinska Institute. Stockholm, Sweden.

 

Gustavo Valbuena, Médico, PhD, Director Masters in Medical

Science program, Center for Biodefense and Emerging

Infectious Diseases, Sealy Center for Vaccine Development

University of Texas Medical Brancha.

 

Alejandro Vélez H. MD. Patólogo, Hospital Pablo Tobón Uribe,

Medellín.

 

Dr. Sócrates Herrera, Médico, Director del Centro Internacional

de Vacunas, Centro de Investigaciones Científicas Caucaseco.

 

Josep Balart Serra MD, Ph.D. Jefe Laboratorio de Radiobiología

Aplicada Laboratorio de Investigación Translacional (IDIBELL)

Instituto Catalán de Oncología

 

Sede Principal Calle 65 Nº 26 - 10 / Tel +57 8781500 Fax 8781501 / Apartado aéreo 275 / Línea gratuita : 01-8000-512120
E-mail ucaldas@ucaldas.edu.co - Condiciones de Uso y Políticas - Contáctenos - FAQ - Manizales - Caldas - Colombia - Número de visitas

Gobierno Universia Ministerio de Educación Colciencias Renata

Pie